Marktanalyse - Emergency Contraception in Slovakia

Emergency contraception grew by 9% in current value terms to reach sales of EUR60,000 in 2011. Escapelle was the only product present at the end of the review period, as it is intended only for exceptional and urgent cases and should not be used as a regular method of contraception. An overall decrease in value growth was evident each year as a result of changing lifestyles of females. In general emergency contraception is considered a last resort for many women as such medication has the...

Euromonitor International's Emergency Contraception in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

EMERGENCY CONTRACEPTION IN SLOVAKIA

Euromonitor International

May 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Emergency Contraception: Value 2006-2011

Table 2 Sales of Emergency Contraception: % Value Growth 2006-2011

Table 3 Emergency Contraception Company Shares by Value 2007-2011

Table 4 Emergency Contraception Brand Shares by Value 2008-2011

Table 5 Forecast Sales of Emergency Contraception: Value 2011-2016

Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Executive Summary

Consumer Health in Slovakia Grows in 2011 Despite Poor Economic Situation

Legislative Change Redefines the Slovak Public Healthcare System

Competition Intensifies As Slovakia Adopts New Rules

Chemists/pharmacies Retains Leading Position in 2011

Constant Growth for Consumer Health Over Forecast Period Is Imminent But Will Face Many Constraints

Key Trends and Developments

OTC Sales Grow in Spite of Unfavourable Economic Conditions

All Major Players Strengthen Their Positions in 2011

Private Label and Availability of Consumer Health in Grocery Retailers Remain Limited

Interest Towards Self-medication and Prevention Is on the Rise

Legislative Changes Dramatically Change Healthcare in Slovakia

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Penetration of Private Label by Category 2006-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Summary 1 OTC - Switches 2011 (from OTC to Rx)

Definitions

Sources

Summary 2 Research Sources

• Emergency Contraception in Canada
• Emergency Contraception in Denmark
• Emergency Contraception in Norway
• Emergency Contraception in Azerbaijan
• Emergency Contraception in China
• Emergency Contraception in Finland
• Emergency Contraception in Kazakhstan
• Emergency Contraception in Latvia
• Emergency Contraception in Lithuania
• Emergency Contraception in Sweden
• Emergency Contraception in the US
• Emergency Contraception in Australia
• Emergency Contraception in Uruguay
• Emergency Contraception in Kenya
• Emergency Contraception in Portugal
• Emergency Contraception in the Netherlands
• Emergency Contraception in Austria
• Emergency Contraception in Nigeria
• Emergency Contraception in Serbia
• HIV-Associated Lipodystrophy Syndrome – Pipeline Review, H2 2012